Clinical Trial Update: Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial from Noxopharm evaluates the safety, tolerability, and pharmacokinetics of the SOF-SKN combination in healthy participants, with Cutaneou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• SOF-SKN

Snippet

Sponsor: Noxopharm Limited | Conditions: Cutaneous Lupus Erythematosus | EARLY_Phase 1 | Status: RECRUITING